🇺🇸 FDA
Pipeline program

ARO-DIMERPA

ARODIMERPA-1001

Phase 2 small_molecule active

Quick answer

ARO-DIMERPA for Hyperlipidemia; Mixed is a Phase 2 program (small_molecule) at ARROWHEAD PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).

Program details

Company
ARROWHEAD PHARMACEUTICALS, INC.
Indication
Hyperlipidemia; Mixed
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials